Kymera Therapeutics (KYMR) Selling, General & Administrative (2019 - 2026)
Kymera Therapeutics (KYMR) reported Selling, General & Administrative of $21.13 million for Q2 2026, up 19.7% from $17.65 million a year earlier and up 3.8% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kymera Therapeutics' Selling, General & Administrative came in at $75.75 million, up 15.3% year-over-year; for FY2025, it was $68.19 million, up 7.3% from FY2024.
- Selling, General & Administrative has increased for six consecutive years, with a five-year compound annual growth rate of 30.2% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $63.53 million in FY2024 (+15.4%), $55.04 million in FY2023 (+25.6%), $43.83 million in FY2022 (+20.6%) and $36.35 million in FY2021 (+99.3%).
- The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q3 2019.
- Year over year, Selling, General & Administrative has now increased in each of the last 14 quarters, with growth averaging 12.5% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q4 2021 (growth of 126.9%); the low point was Q3 2022 (a decline of 1.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $20.36 million (Q1 2026), $16.94 million (Q4 2025) and $17.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Kymera Therapeutics | 8.89 Bn | 6.19 Bn | - | 21.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.13 Mn |
| Mar 31, 2026 | 20.36 Mn |
| Dec 31, 2025 | 16.94 Mn |
| Sep 30, 2025 | 17.34 Mn |
| Jun 30, 2025 | 17.65 Mn |
| Mar 31, 2025 | 16.27 Mn |
| Dec 31, 2024 | 16.33 Mn |
| Sep 30, 2024 | 15.46 Mn |
| Jun 30, 2024 | 17.37 Mn |
| Mar 31, 2024 | 14.37 Mn |
| Dec 31, 2023 | 14.23 Mn |
| Sep 30, 2023 | 14.12 Mn |
| Jun 30, 2023 | 14.13 Mn |
| Mar 31, 2023 | 12.57 Mn |
| Dec 31, 2022 | 11.64 Mn |
| Sep 30, 2022 | 10.56 Mn |
| Jun 30, 2022 | 11.03 Mn |
| Mar 31, 2022 | 10.61 Mn |
| Dec 31, 2021 | 11.74 Mn |
| Sep 30, 2021 | 10.67 Mn |
API Access
Kymera Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();